Heparin-coated cardiopulmonary bypass circuit: Clinical effects in pediatric cardiac surgery

被引:16
|
作者
Miyaji, K [1 ]
Hannan, RL [1 ]
Ojito, J [1 ]
Jacobs, JP [1 ]
White, JA [1 ]
Burke, RP [1 ]
机构
[1] Miami Childrens Hosp, Dept Cardiovasc Surg, Miami, FL USA
关键词
D O I
10.1111/j.1540-8191.2000.tb00456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Heparin-coated cardiopulmonary bypass (CPB) circuits have been reported to reduce complement activation and the inflammatory response associated with CPB. We retrospectively compared patients utilizing heparin-coated perfusion circuits with those using noncoated circuits to determine the clinical effects of the different circuits in pediatric cardiac surgery. Methods: Between July 1995 and July 1997, 203 patients weighing < 10 kg underwent cardiac surgery, 153 patients using heparin-coated bypass circuits and 50 patients using noncoated circuits. The 50 patients operated on with the noncoated circuit (Group N) were matched to 100 patients operated on with coated circuits (Group H) in age, weight, and type of procedure. Urine output during bypass, blood products used after bypass, postoperative ventilation days, hospital stay, morbidity, and mortality were compared between these groups. Results: Body weight, perfusion time, and procedure time were not different between the two groups. Urine output during bypass was notably greater in Group H than in Group hi (11.3 +/- 10.5 mL/kg per hour vs 4.8 +/- 3.1 mL/kg per hour, respectively, p < 0.0001). Postoperative mechanical ventilation markedly decreased in Group H (Group H vs hi = 2.8 +/- 2.7 days vs 5.1 +/- 7.5 days, respectively, p < 0.05). Red blood cell usage, hospital stay, morbidity, and mortality were not statistically different, although there was a tendency toward decreased transfusion of red cell and platelets in Group H (Group H vs N = 61.2 +/- 121.1 mL/kg vs 102.0 +/- 176.7 mL/kg, respectively, in red cell, p = 0.15; and Group H vs hi = 7.9 +/- 13.7 mL/kg vs 13.2 +/- 24.5 mL/kg, respectively, in platelets, p = 0.16). Conclusions: Patients operated on with the use of heparin-coated circuits had increased urine output during bypass and required less time postoperatively on the ventilator. These results suggest a reduction in the acute inflammatory response, capillary leakage, and overall systemic edema. We now routinely use coated circuits on all pediatric pump cases.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [1] Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass
    Kagisaki, K
    Masai, T
    Kadoba, K
    Sawa, Y
    Nomura, F
    Fukushima, N
    Ichikawa, H
    Ohata, T
    Suzuki, K
    Taketani, S
    Matsuda, H
    ARTIFICIAL ORGANS, 1997, 21 (07) : 836 - 840
  • [2] Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery
    Horimoto, H
    Kondo, K
    Asada, K
    Sasaki, S
    ARTIFICIAL ORGANS, 1996, 20 (08) : 936 - 940
  • [3] USE OF HEPARIN-COATED CARDIOPULMONARY BYPASS
    JONES, DR
    HILL, RC
    HOLLINGSED, MJ
    STULLKEN, E
    GRAEBER, GM
    GUSTAFSON, RA
    MURRAY, GF
    ANNALS OF THORACIC SURGERY, 1993, 56 (03): : 556 - 558
  • [4] HEPARIN-COATED CARDIOPULMONARY BYPASS CIRCUIT FOR USE DURING LUNG TRANSPLANTATION
    GU, YJ
    VANOEVEREN, W
    BOONSTRA, PW
    DEBOER, WJ
    EBELS, T
    PROP, J
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1995, 14 (03): : 605 - 606
  • [5] Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass
    Baufreton, Christophe
    Le Besnerais, Paul
    Jansen, Piet
    Mazzucotelli, Jean Philippe
    Wildevuur, Charles R. H.
    Loisance, Daniel Y.
    PERFUSION-UK, 1996, 11 (06): : 437 - 443
  • [6] Heparin-coated bypass circuits: Effects on inflammatory response in pediatric cardiac operations
    Schreurs, HH
    Wijers, MJ
    Gu, YJ
    van Oeveren, W
    van Domburg, RT
    de Boer, JH
    Bogers, AJJC
    ANNALS OF THORACIC SURGERY, 1998, 66 (01): : 166 - 171
  • [7] Heparin-coated (Carmeda) oxygenators in pediatric cardiac surgery
    Stover, EP
    Reitz, BA
    Hood, PA
    Welsh, JG
    ANESTHESIOLOGY, 1999, 91 (3A) : U144 - U144
  • [8] Heparin-coated (Carmeda) oxygenators in pediatric cardiac surgery
    Stover, EP
    Reitz, BA
    Hood, PA
    ANESTHESIA AND ANALGESIA, 1999, 88 (04): : U45 - U45
  • [9] Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting
    Mirow, N
    Minami, K
    KLeikamp, G
    Tenderich, G
    Puhlmann, T
    Körfer, R
    THORACIC AND CARDIOVASCULAR SURGEON, 2001, 49 (03): : 131 - 136
  • [10] Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not
    Levy, M
    Hartman, AR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 : S81 - S87